These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32711158)

  • 1. Dehydroepiandrosterone and age-related musculoskeletal diseases: Connections and therapeutic implications.
    Huang K; Cai HL; Bao JP; Wu LD
    Ageing Res Rev; 2020 Sep; 62():101132. PubMed ID: 32711158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging.
    Ladang A; Beaudart C; Reginster JY; Al-Daghri N; Bruyère O; Burlet N; Cesari M; Cherubini A; da Silva MC; Cooper C; Cruz-Jentoft AJ; Landi F; Laslop A; Maggi S; Mobasheri A; Ormarsdottir S; Radermecker R; Visser M; Yerro MCP; Rizzoli R; Cavalier E
    Calcif Tissue Int; 2023 Feb; 112(2):197-217. PubMed ID: 36633611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dehydroepiandrosterone(DHEA)and bone metabolism].
    Ohnaka K
    Clin Calcium; 2016 Jul; 26(7):987-93. PubMed ID: 27346309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of sarcopenia with and without fracture.
    Tarantino U; Baldi J; Scimeca M; Piccirilli E; Piccioli A; Bonanno E; Gasbarra E
    Injury; 2016 Oct; 47 Suppl 4():S3-S10. PubMed ID: 27496721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria and cellular senescence: Implications for musculoskeletal ageing.
    Habiballa L; Salmonowicz H; Passos JF
    Free Radic Biol Med; 2019 Feb; 132():3-10. PubMed ID: 30336251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for optimising musculoskeletal health in the 21
    Lewis R; Gómez Álvarez CB; Rayman M; Lanham-New S; Woolf A; Mobasheri A
    BMC Musculoskelet Disord; 2019 Apr; 20(1):164. PubMed ID: 30971232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuropsychic effects of dehydroepiandrosterone].
    Rigaud AS; Pellerin J
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS43-9. PubMed ID: 11435994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DHEA, important source of sex steroids in men and even more in women.
    Labrie F
    Prog Brain Res; 2010; 182():97-148. PubMed ID: 20541662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of dehydroepiandrosterone in modulating osteoarthritis-related pain.
    Huang K; Cai HL; Wu LD
    Steroids; 2019 Oct; 150():108433. PubMed ID: 31229511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone Morphogenetic Proteins and myostatin pathways: key mediator of human sarcopenia.
    Scimeca M; Piccirilli E; Mastrangeli F; Rao C; Feola M; Orlandi A; Gasbarra E; Bonanno E; Tarantino U
    J Transl Med; 2017 Feb; 15(1):34. PubMed ID: 28202082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Juvenile hormones, reality or myth?].
    Vermeulen A
    Verh K Acad Geneeskd Belg; 1997; 59(1):19-33. PubMed ID: 9221619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current views on the role of dehydroepiandrosterone in physiology, pathology and therapy].
    Krysiak R; Frysz-Naglak D; Okopień B
    Pol Merkur Lekarski; 2008 Jan; 24(139):66-71. PubMed ID: 18634257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial?
    Samaras N; Samaras D; Frangos E; Forster A; Philippe J
    Rejuvenation Res; 2013 Aug; 16(4):285-94. PubMed ID: 23647054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dehydroepiandrosterone: Molecular mechanisms and therapeutic implications in osteoarthritis.
    Huang K; Wu LD
    J Steroid Biochem Mol Biol; 2018 Oct; 183():27-38. PubMed ID: 29787833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia: a histological and immunohistochemical study on age-related muscle impairment.
    Tarantino U; Scimeca M; Piccirilli E; Tancredi V; Baldi J; Gasbarra E; Bonanno E
    Aging Clin Exp Res; 2015 Oct; 27 Suppl 1():S51-60. PubMed ID: 26197719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Musculoskeletal system as a target organ of a frailty processes].
    Zlobina IA; Krivtsunov AN; Bogat SV; Prashchayeu KI
    Adv Gerontol; 2015; 28(4):725-728. PubMed ID: 28509462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring the musculoskeletal aging phenotype.
    Dawson A; Dennison E
    Maturitas; 2016 Nov; 93():13-17. PubMed ID: 27131919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dehydroepiandrosterone and diseases of aging.
    Watson RR; Huls A; Araghinikuam M; Chung S
    Drugs Aging; 1996 Oct; 9(4):274-91. PubMed ID: 8894525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. East meets West: current practices and policies in the management of musculoskeletal aging.
    Xia W; Cooper C; Li M; Xu L; Rizzoli R; Zhu M; Lin H; Beard J; Ding Y; Yu W; Cavalier E; Zhang Z; Kanis JA; Cheng Q; Wang Q; Reginster JY
    Aging Clin Exp Res; 2019 Oct; 31(10):1351-1373. PubMed ID: 31376119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of musculoskeletal diseases on mortality-comparison with internal diseases: A 15-year longitudinal study.
    Kasai T; Hasegawa Y; Imagama S; Sakai T; Wakai K; Suzuki K; Ishiguro N
    J Orthop Sci; 2017 Nov; 22(6):1126-1131. PubMed ID: 28754502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.